Stand Up To Cancer
- Company typePrivate
- Founded2008
- HeadquartersLos Angeles, United States
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Stand Up To Cancer does
Stand Up To Cancer (SU2C) is a 501(c)(3) charitable organization founded in 2008 as a division of the Entertainment Industry Foundation and now operating independently with headquarters in Los Angeles. The organization functions as a research-funder and awareness vehicle rather than a product vendor: it channels philanthropic donations into collaborative cancer research programs - specifically Dream Teams (multi-institution flagship grants), SU2C Catalyst (early-stage combination and immunotherapy clinical trials), SU2C Convergence (interdisciplinary integration of medical, physical, and computational sciences including AI/ML), and Innovative Research Grants for early-career scientists. To date, SU2C has raised over $800 million, supported 3,100+ researchers across 210+ institutions in 16+ countries, funded 280+ clinical trials enrolling 37,000+ patients, and attributes 11+ scientific breakthroughs to its grants, including FDA approvals in breast, prostate, colorectal, melanoma, and sarcoma indications.
SU2C's operational engine is a peer-reviewed grant process administered in partnership with the American Association for Cancer Research (AACR), supplemented by a public-facing awareness and fundraising apparatus built around biennial 'roadblock' televised fundraising specials that air simultaneously on major US broadcast networks and 55+ platforms, plus the ninth such special aired August 2025. Complementary programs include the 'I Stand Up' placard campaign, peer-to-peer fundraising pages, the SU2C Stream Team for online creators, MLB-integrated placements (All-Star/World Series, AbbVie/MLB 'Striking Out Cancer' with $20 per strikeout up to $1M/season), corporate matching gifts, merchandise sales via Droppd.com, planned giving, DAF giving (Chariot/DAFpay), stock donations (DonateStock), and airline-miles incentivized donations via the American Airlines AAdvantage program.
Revenue is 100% philanthropic, drawn from individual one-time and recurring donations ($25-$500+ tiers plus custom amounts), corporate sponsorships (AbbVie, Bristol-Myers Squibb, Genentech, Merck, American Airlines, Mastercard, Lustgarten, Exact Sciences, Van Andel Institute, Boehringer Ingelheim, Day One, Gilead/Kite), corporate matching gifts at 1:1 to 4:1 ratios, peer-to-peer fundraising, planned giving/bequests, DAF grants, stock/vehicle/real estate gifts, e-commerce merchandise, and foundation grants (including Cancer Research UK and Mirati Therapeutics). SU2C serves four principal stakeholder groups: individual donors and celebrity ambassadors (1,100+), corporate partners and sponsors, the scientific research community across 210+ institutions, and cancer patients/survivors/caregivers who benefit from funded clinical trials and share stories to drive donations. The organization is governed by a Board chaired by Sherry Lansing and led operationally by President and CEO Julian Adams, PhD.
Stand Up To Cancer firmographics
Firmographics- Name
- Stand Up To Cancer
- Legal name
- Stand Up To Cancer
- Website
- https://standuptocancer.org
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Stand Up To Cancer industry classification
Industry- Product category
- Cancer Research Funding
- NAICS
- Voluntary Health Organizations (813212), Grantmaking Foundations (813211)
- akta.pro primary industry
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
- akta.pro secondary industry
- Health & Medical Research Grantmaking Foundations (BPAGAKAL)
Keywords
Where Stand Up To Cancer is headquartered
LocationHeadquarters
- HQ city
- Los Angeles
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Stand Up To Cancer business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Operations, Others
Revenue model
- Individual Donations: One-time and recurring donations from individual supporters via the website, mail, and phone. Donation amounts include preset tiers ($25, $50, $80, $100, $300, $500 and custom). Donors can set up monthly giving. Donations are tax-deductible for US donors.
- Peer-to-Peer Fundraising Campaigns: Supporters create personal fundraising pages for events such as birthdays, sporting events, anniversaries, or in honor of loved ones. SU2C provides tools and platforms for campaign management and donor tracking.
- Stock Donations: Donors can transfer appreciated stock directly to SU2C via a DonateStock-powered portal, avoiding capital gains taxes while allowing SU2C to receive the full market value.
- Planned Giving and Legacy Gifts: Planned giving options include charitable bequests (wills and bequests), IRA rollovers (for donors 70½+), beneficiary designation on retirement assets, gifts of insurance, and gifts of real estate. These create long-term funding streams.
- Donor-Advised Fund (DAF) Grants: Donors direct grants to SU2C from their Donor-Advised Funds. SU2C partners with Chariot for DAFpay, enabling instant 3-click grants from Fidelity, Schwab, Vanguard, and other DAF providers.
- Corporate Matching Gifts: Corporate employers match employee donations to SU2C, with some companies matching at 1:1, 2:1, 3:1, or 4:1 ratios, amplifying individual donation impact.
- Corporate Sponsorships and Philanthropic Partnerships: Pharmaceutical companies (e.g., AbbVie, Bristol-Myers Squibb, Genentech, Merck), entertainment companies, and other corporations provide funding, product donations (e.g., PXG golf clubs for events), and cause marketing integration. MLB partnership with AbbVie includes $20 per strikeout donation up to $1M per season.
- E-commerce Merchandise Sales: Exclusive Stand Up To Cancer merchandise sold through Droppd.com storefront. Proceeds support cancer research.
- AA AAdvantage Miles Program: Donors receive 10 American Airlines AAdvantage bonus miles per dollar donated on gifts of $25 or more, incentivizing airline loyalty program members to give.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Monthly | One-time or monthly donation amounts ranging from $25 to $500+ |
| Other | One time | American Airlines AAdvantage miles earning on donations |
| One time/ perpetual license | Pay-as-you-go | Merchandise purchases through Droppd.com storefront |
Go-to-market motion3 records
Distribution channels8 records
Marketing channels10 records
Stand Up To Cancer product offering
Product offeringCore offering
Stand Up To Cancer is a 501(c)(3) charitable organization that raises and grants funds to support collaborative cancer research. The organization solicits donations through televised fundraising specials, peer-to-peer digital fundraising, corporate sponsorships, and planned giving, then channels proceeds into collaborative research programs including Dream Teams, SU2C Convergence, SU2C Catalyst, and Innovative Research Grants administered in partnership with the American Association for Cancer Research. Since 2008, SU2C has raised over $800 million supporting 3,100+ researchers across 210+ institutions and funding 280+ clinical trials.
Product overview
Stand Up To Cancer is a 501(c)(3) charitable organization that functions as a collaborative cancer research movement rather than a traditional product company. The organization operates a digital fundraising platform featuring the Create Your Placard tool as its primary interactive consumer product, enabling supporters to generate personalized digital placards honoring loved ones. Supporting products include stock donation integration (via DonateStock), DAF giving (via Chariot), and American Airlines AAdvantage® miles earning program. The organization conducts televised fundraising specials (SU2C Show), manages the SU2C Stream Team creator community for peer-to-peer fundraising, operates the SU2C Exchange collaboration platform for researchers and pharmaceutical partners, and offers an official merchandise store. The core value proposition centers on channeling donations into collaborative cancer research programs including Dream Teams, SU2C Convergence, and SU2C Catalyst initiatives.
Differentiator
Problem solved
Functional benefit
Brands
- SU2C Convergence: Program integrating medical, physical, and computational sciences to explore big questions about cancer biology using AI approaches.
- SU2C Catalyst
- SU2C Dream Teams
- SU2C Stream Team
Products and services
- Create Your Placard Standalone interactive digital tool that allows supporters to create personalized placards honoring loved ones in the fight against cancer. Users enter their information and the honoree's name to generate a shareable digital placard for social media. It serves individual donors and advocates seeking to publicly honor cancer patients and survivors.
- SU2C Show Biennial televised roadblock fundraising special featuring entertainment industry stars, cancer researchers, and survivors. The broadcast airs simultaneously across major broadcast networks and more than 55 streaming and media platforms to raise awareness and donations for cancer research. It serves individual donors, corporate sponsors, and entertainment-industry partners.
- SU2C Stream Team A community of streamers and creators who fundraise for SU2C through gaming and content creation on Twitch, YouTube, and other platforms. Includes structured programs such as #Up2Us (August fundraising streams) and #UniteAcrossPlatforms (year-end campaign starting on Giving Tuesday). It serves streamers and younger donor demographics seeking peer-to-peer engagement.
- SU2C Exchange A collaboration platform connecting SU2C grantees, applicants, and researchers with pharmaceutical and biotechnology companies (Exchange Members including Boehringer Ingelheim, Day One Biopharma, and Gilead-Kite) to facilitate partnerships and bring new technologies to cancer research projects. It serves investigators, pharmaceutical R&D teams, and biotech partners seeking translational research collaboration.
- SU2C Merchandise Store Official e-commerce merchandise storefront operated through Droppd.com offering exclusive Stand Up To Cancer branded apparel and accessories. Proceeds from each sale support cancer research, and the storefront serves individual supporters seeking branded merchandise to demonstrate advocacy.
Quantifiable outcome
- Over 11 scientific breakthroughs attributed to SU2C-funded research, including new FDA-approved therapies for breast cancer, prostate cancer, colorectal cancer, melanoma, and sarcoma.
- +4 more outcomes
Companies that use Stand Up To Cancer
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Stand Up To Cancer technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability8 records
Feature5 records
Stand Up To Cancer partnerships and signals
Strategic signalPartnerships
17 partnerships are on record, tiered flagship, core, major and minor.
- AbbVie / Major League BaseballflagshipAbbVie entered a multi-year partnership with Major League Baseball becoming the Official Pharmaceutical Partner of MLB beginning with the 2026 season, expanding its 'Striking Out Cancer' campaign league-wide. AbbVie will donate $20 for every strikeout during the season, up to $1 million maximum, benefiting Stand Up To Cancer. Approximately 40,000 strikeouts are recorded across MLB each season. The campaign is integrated across all MLB games, platforms, and key events including the All-Star Game and Postseason Wild Card Series.
- Cancer Research UKflagshipStand Up To Cancer and Cancer Research UK jointly announced extended funding of $3 million for the SU2C Gastric Cancer Interception Dream Team to launch a clinical trial testing a novel fluorescence-guided endoscopy approach for early detection of gastric cancer. The international team spans institutions in the US, UK, and South Korea, and will also validate the ORF1p blood biomarker and expand stool-based biomarker research.
- Johnson & JohnsoncoreSU2C announced funding for a Los Angeles-based research team to explore new treatments for AL amyloidosis, a rare blood cancer. The research involves a clinical trial testing a combination of targeted therapies (teclistamab and daratumumab) in newly diagnosed patients, supported by a collaboration with Johnson & Johnson.
- American AirlinescoreAmerican Airlines is a Visionary-level partner of SU2C. The partnership includes the AA AAdvantage miles-for-donations program, where donors earn 10 bonus miles per dollar on donations of $25 or more, and co-branded awareness campaigns.
- Bristol-Myers Squibb (BMS)coreBMS is listed as a Luminaries-level supporter of Stand Up To Cancer, contributing through pharmaceutical research partnerships and cause marketing initiatives.
- MastercardcoreMastercard is a Luminaries-level partner supporting SU2C through consumer-facing campaigns and branded merchandise integrations at major events.
- GenentechcoreGenentech is listed as a Luminaries-level supporter of SU2C, contributing through pharmaceutical research partnerships and cancer awareness campaigns.
- Lustgarten FoundationcoreThe Lustgarten Foundation is a Luminaries-level partner collaborating with SU2C on pancreatic cancer research and awareness initiatives.
- MerckmajorMerck is listed as a Heroes-level partner supporting SU2C's mission through pharmaceutical research partnerships and cancer awareness campaigns.
- Van Andel InstitutemajorVan Andel Institute is a Heroes-level partner contributing to SU2C's research programs and scientific collaboration initiatives.
- Exact SciencesmajorExact Sciences is a Heroes-level partner supporting SU2C, likely through early detection and diagnostic research collaborations.
- American Association for Cancer Research (AACR)flagshipThe AACR is SU2C's scientific partner, conducting the rigorous peer review of grants administered on behalf of SU2C. The AACR also manages the Scientific Advisory Committee review process in collaboration with SU2C leadership.
- Boehringer IngelheimminorBoehringer Ingelheim is an Exchange-level member of SU2C, participating in the SU2C Exchange program that connects product developers and research service providers with leading investigators in SU2C-funded research.
- Day One BiopharmaceuticalsminorDay One Biopharmaceuticals is an Exchange-level member of SU2C, connecting with investigators in the SU2C research community through the Exchange program.
- Gilead / Kite PharmaminorGilead-Kite is an Exchange-level member of SU2C, participating in the SU2C Exchange program focused on cell therapy and cancer research collaborations.
- Arizona Diamondbacks / Upper Deck GolfminorThe Arizona Diamondbacks partnered with Upper Deck Golf to transform Chase Field into a golfing event on July 24-25, 2026, raising money for Stand Up To Cancer. PXG supplied golf clubs for participants.
- Moffitt Cancer Centerminor'This is where the end of cancer begins' tagline is used with Moffitt Cancer Center's permission; 'The End of Cancer Begins Here' is a registered trademark of Moffitt Cancer Center.
Scale indicators15 records
Recent moves8 records
Expansion highlights6 records
Stand Up To Cancer competitors and assessment
Company assessmentDirect peers
- Susan G. Komen: Disease-specific (breast cancer) research and patient support nonprofit. Comparable fundraising scale and event-driven model (Race for the Cure), competing for the same corporate sponsors and individual donor base.
- Lustgarten Foundation: Pancreatic cancer-specific research funder and current SU2C Luminaries-level partner. Disease-narrower than SU2C but directly comparable in collaborative-grantmaking model and corporate fundraising.
- American Cancer Society: The largest US cancer charity, funding research, patient support, and advocacy. Directly competes with SU2C for cancer-research donor dollars, but operates a broader, year-round fundraising engine rather than event-driven specials.
- Cancer Research UK: The UK's largest cancer charity and a direct co-funder with SU2C on the $3M Gastric Cancer Dream Team. Operates a similar research-grantmaking model and is an active collaboration partner, not just a peer.
- V Foundation for Cancer Research: Cancer research grantmaking nonprofit founded by Jim Valvano. Closely comparable to SU2C in model — funding translational research through collaborative teams and leveraging sports/celebrity networks for fundraising.
- Leukemia & Lymphoma Society: Disease-focused (blood cancers) research and patient services nonprofit. Similar grantmaking-funded research model with comparable individual and corporate donor engagement programs.
Broad incumbents
- National Cancer Institute: The US federal government's principal agency for cancer research and training. A much larger, publicly funded incumbent that competes for top research talent and sets the agenda SU2C-funded work must complement.
Emerging players
- Memorial Sloan Kettering Cancer Center: A major SU2C-funded research institution that runs its own large-scale philanthropic operation. Functions as both a grantee of SU2C and a competitor for cancer-research donor dollars.
- Pancreatic Cancer Action Network (PanCAN): Disease-specific (pancreatic) research and advocacy nonprofit. Smaller than SU2C in scope but directly comparable in collaborative research grantmaking and patient-services-plus-fundraising dual mission.
Others
- Entertainment Industry Foundation: SU2C's parent organization. Operates as a Hollywood-coordinated charitable platform that houses multiple cause campaigns; SU2C is its largest division and uses EIF's entertainment industry relationships as a structural asset.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks4 records
Key highlights6 records
Customer concentration
Stand Up To Cancer social profiles
Digital presenceStand Up To Cancer financial estimates
Financial estimateRevenue estimate
Valuation estimate
Stand Up To Cancer leadership team
Management profileNumber of profiles
Profiles20 records
Stand Up To Cancer funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Stand Up To Cancer M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Stand Up To Cancer
What does Stand Up To Cancer do?
Stand Up To Cancer is a 501(c)(3) charitable organization that raises and grants funds to support collaborative cancer research. The organization solicits donations through televised fundraising specials, peer-to-peer digital fundraising, corporate sponsorships, and planned giving, then channels proceeds into collaborative research programs including Dream Teams, SU2C Convergence, SU2C Catalyst, and Innovative Research Grants administered in partnership with the American Association for Cancer Research. Since 2008, SU2C has raised over $800 million supporting 3,100+ researchers across 210+ institutions and funding 280+ clinical trials.
Is Stand Up To Cancer a public or private company?
Stand Up To Cancer is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Stand Up To Cancer founded?
Stand Up To Cancer was founded in 2008. It employs 51 to 100 people.
Where is Stand Up To Cancer based?
Stand Up To Cancer is headquartered in Los Angeles, United States, in the North America region.
How does Stand Up To Cancer make money?
Nine revenue lines are on record. Individual Donations are the primary driver. The others are peer-to-Peer Fundraising Campaigns, stock Donations, planned Giving and Legacy Gifts, donor-Advised Fund (DAF) Grants, corporate Matching Gifts, corporate Sponsorships and Philanthropic Partnerships, E-commerce Merchandise Sales and AA AAdvantage Miles Program.
Who are Stand Up To Cancer's main competitors?
Direct peers on record are Susan G. Komen, Lustgarten Foundation, American Cancer Society, Cancer Research UK, V Foundation for Cancer Research and Leukemia & Lymphoma Society. National Cancer Institute is listed as a broad incumbent. Emerging players are Memorial Sloan Kettering Cancer Center and Pancreatic Cancer Action Network (PanCAN). Entertainment Industry Foundation is listed as an others.
Does Stand Up To Cancer have an API?
No public API is recorded for Stand Up To Cancer.
What industry is Stand Up To Cancer in?
Stand Up To Cancer's product category is Cancer Research Funding. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813212.